GlassScriptPhysician profile
Michael I Nahhas
NPI 1427431469
$9,657.34
in general payments reported to CMS, 2019-2025
22 companies · $802 in 2025
The $802 reported for 2025 was more than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $17.04 · 2021: $1,929 · 2022: $4,778 · 2023: $807 · 2024: $802 · 2025: $802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,410.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,573.92 | 2021-2024 | Red 72 |
| Medtronic, INC. | $1,547.95 | 2021-2022 | |
| Microvention, INC. | $1,477.33 | 2021-2023 | Phil, Web Aneurysm Embolization System, Headway Advanced Soft |
| Imperative Care, INC | $1,383.70 | 2021-2024 | Zoom Rdl Radial Access System, 103cm, Zoom 88-T Large Distal Platform, Tracstar Large Distal Platform |
| Depuy Synthes Sales INC. | $1,086.02 | 2019-2025 | Trufill, Emboguard, Embotrap |
| Viz.Ai, INC. | $335.14 | 2022 | |
| Stryker Corporation | $264.17 | 2023-2025 | Broadway 8, Trevo, Target |
| Qapel Medical INC | $183.84 | 2022 | |
| Route 92 Medical, INC. | $170.75 | 2025 | |
| Sunovion Pharmaceuticals INC. | $153.20 | 2019 | |
| Silk Road Medical, INC. | $150.84 | 2022 | |
| Supernus Pharmaceuticals, INC. | $56.97 | 2019 | |
| Greenwich Biosciences, INC. | $52.63 | 2019 | |
| Pfizer INC. | $34.69 | 2019 | |
| Amgen INC. | $30.27 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Balt USA, LLC | $29.05 | 2022 | |
| Cardiva Medical, INC. | $28.89 | 2025 | Cardiva Vascade 5f Vcs |
| Portola Pharmaceuticals, LLC | $27.67 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.80 | 2023 | |
| Eisai INC. | $20.20 | 2019 | |
| Asahi Intecc USA, INC. | $12.75 | 2024 | Peripheral Vascular |
| Allergan, INC. | $12.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nahhas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.